Syra Health Corp. SYRA
$0.91
$0.022.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.32% | -5.51% | -9.47% | -3.14% | 14.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.32% | -5.51% | -9.47% | -3.14% | 14.07% |
| Cost of Revenue | -14.20% | -22.35% | -25.14% | -9.83% | 8.24% |
| Gross Profit | 35.73% | 47.75% | 50.50% | 17.44% | 31.29% |
| SG&A Expenses | -17.06% | -29.46% | -30.74% | -34.99% | -28.03% |
| Depreciation & Amortization | -79.17% | -74.04% | -67.30% | -62.39% | -16.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.90% | -27.57% | -30.79% | -26.87% | -15.15% |
| Operating Income | 105.09% | 91.41% | 75.98% | 70.10% | 64.76% |
| Income Before Tax | 108.97% | 93.42% | 76.16% | 70.21% | 65.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 108.97% | 93.42% | 76.16% | 70.21% | 65.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 108.97% | 93.42% | 76.16% | 70.21% | 65.18% |
| EBIT | 105.09% | 91.41% | 75.98% | 70.10% | 64.76% |
| EBITDA | 107.52% | 96.13% | 79.35% | 73.01% | 68.23% |
| EPS Basic | 105.81% | 95.75% | 85.93% | 79.32% | 73.58% |
| Normalized Basic EPS | 105.89% | 95.78% | 85.95% | 79.34% | 73.60% |
| EPS Diluted | 105.51% | 94.39% | 85.06% | 78.49% | 72.77% |
| Normalized Diluted EPS | 104.65% | 95.42% | 85.95% | 79.34% | 73.60% |
| Average Basic Shares Outstanding | 20.59% | 35.32% | 56.97% | 32.14% | 29.48% |
| Average Diluted Shares Outstanding | 23.59% | 37.70% | 56.97% | 32.14% | 29.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |